Follow
Olga Bruyaka
Title
Cited by
Cited by
Year
Do science and money go together? The case of the French biotech industry
R Durand, O Bruyaka, V Mangematin
Strategic Management Journal 29 (12), 1281-1299, 2008
1122008
Run away or stick together? The impact of organization-specific adverse events on alliance partner defection
O Bruyaka, D Philippe, X Casta˝er
Academy of Management Review 43 (3), 445-469, 2018
562018
Sell-off or shut-down? Alliance portfolio diversity and two types of high tech firms’ exit
O Bruyaka, R Durand
Strategic Organization 10 (1), 7-30, 2012
542012
Strategic corporate social responsibility and orphan drug development: Insights from the US and the EU biopharmaceutical industry
O Bruyaka, HK Zeitzmann, I Chalamon, RE Wokutch, P Thakur
Journal of Business Ethics 117 (1), 45-65, 2013
502013
Flow signals: Evidence from patent and alliance portfolios in the US biopharmaceutical industry
T Caner, O Bruyaka, JE Prescott
Journal of Management Studies 55 (2), 232-264, 2018
482018
Better at home, abroad, or both? How Chinese firms use ambidextrous internationalization strategies to drive innovation
C Prange, O Bruyaka
Cross Cultural & Strategic Management, 2016
322016
Impact of HIPAA provisions on the stock market value of healthcare institutions, and information security and other information technology firms
L Khansa, DF Cook, T James, O Bruyaka
Computers & Security 31 (6), 750-770, 2012
322012
Investigating the transformation and transition processes between dynamic capabilities: evidence from DHL
C Prange, O Bruyaka, K Marmenout
Organization Studies 39 (11), 1547-1573, 2018
202018
Antecedents and relative performance of sourcing choices for new product development projects
P Thakur-Wernz, O Bruyaka, F Contractor
Technovation 90, 102097, 2020
172020
Co-evolutionary perspective on sourcing portfolios: Examining sourcing choices for clinical trials of bio-pharmaceutical firms
P Thakur-Wernz, O Bruyaka
Management International Review 57 (6), 909-946, 2017
162017
Using network-based text analysis to analyze trends in Microsoft's security innovations
TL James, L Khansa, DF Cook, O Bruyaka, KB Keeling
computers & security 36, 49-67, 2013
132013
ALLIANCE PARTNER DIVERSITY AND BIOTECH FIRMS'EXIT: DIFFERING EFFECTS ON DISSOLUION VS. DIVESTMENT.
OP BRUYAKA
Academy of management proceedings 2008 (1), 1-6, 2008
102008
Reexamining CEO duality: The surprisingly problematic issues of conceptualization and measurement
S Gove, M Junkunc, O Bruyaka, LR Kabbach de Castro, ...
Corporate Governance: An International Review 25 (6), 411-427, 2017
72017
Strategic network orchestration in emerging markets: China's catch‐up in the high‐speed train industry
H Rui, O Bruyaka
British Journal of Management 32 (1), 97-123, 2021
62021
Strategic complementarities in M&As: evidence from the US information retrieval services industry
O Bruyaka, T James, DF Cook, R Barkhi
Information Technology and Management 16 (2), 97-116, 2015
42015
Performance de la RD Le cas des biotechnologies franšaises1
O Bruyaka
Revue franšaise de gestion 31 (155), 23, 2005
42005
Measuring Dynamic Capabilities: A Construct-Level Analysis of Empirical Studies
CI Prange, O Bruyaka, H Li
Academy of Management Proceedings 2018 (1), 13227, 2018
22018
Overcoming innovation barriers: Alliance portfolio characteristics and technological innovations
MK Srivastava, O Bruyaka, DR Gnyawali
22013
International cultural ambidexterity: Balancing tensions of foreign market entry into distant and proximate cultures
O Bruyaka, C Prange
Journal of Business Research 118, 491-506, 2020
12020
Tapping Regional And Corporate Scientific Knowledge For Innovation: The Moderating Role Of Scientific Knowledge Duration
O Bruyaka, FX Ji, LF Tegarden, DE Hatfield, WB Lamb
International Journal of Innovation Management 19 (01), 1550001, 2015
12015
The system can't perform the operation now. Try again later.
Articles 1–20